Breast Cancer experts lead a discussion on incorporating newly approved drugs into the breast cancer treatment armamentarium focusing on what is Standard of Care.
The Who, When, Where, and How of PARP Inhibition. Linking the biology, the disease, and the treatment.
The Who, When, Where, and How of PARP Inhibition. Linking the biology, the disease, and the treatment.
The Who, When, Where, and How of PARP Inhibition. Linking the biology, the disease, and the treatment.
With therapeutic advances in lung cancer coming fast and furious, hear from recognized lung cancer experts on how the treatment landscape is evolving. Must be a healthcare professional to attend.
